# Frank Lis

> Frank Lis is a Series A investor at Kineticos Ventures backing Biotechnology. See 3 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Kineticos Ventures](https://shizune.co/investors/profile/kineticos-ventures)
- Location: Doylestown, United States
- Total investments: 3
- Last investment: May 2023
- Lead investor: 67%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/frank-lis-60a5515/

Frank Lis is a Series A investor at Kineticos Ventures in Doylestown focused on Biotechnology and Health Care. Frank Lis is the current President and CEO of Kineticos Ventures. He previously worked at Sharp Clinical Services as a President. Frank Lis attended Villanova University.

## Contacts

5 contacts available for Frank Lis: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/frank-lis-a5be?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 100% |
| Health Care | 2 | 67% |
| Life Science | 2 | 67% |
| Wellness | 1 | 33% |
| Clinical Trials | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 2 | 67% |
| United States | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| eXmoor Pharma | eXmoor Pharma is a technical and strategic consultancy specializing in cell and gene therapies (ATMPs) and biopharmaceuticals. | $35M | Series A | May 30, 2023 | http://www.exmoorpharma.com/ |
| Inceptor Bio | Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers, with a focus on novel mechanisms to improve immune cell performance in the tumor microenvironment. Inceptor Bio provides a partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of their lab andmanufacturing resources with the industry experience of their cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency. | $37M | Series A | May 19, 2022 | https://www.inceptor.bio |
| EnteroBiotix | EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome-modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in thehuman gut, enabling physicians to prevent and treat debilitating infections and diseases. | $21.4M | Series A | Sep 07, 2021 | http://enterobiotix.com/ |

3 of 3 investments shown.

## Co-investors
- [MVM Life Science Partners](https://shizune.co/investors/profile/mvm-life-science-partners) — VC Fund, 1 deal together
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund, 1 deal together
- [SIS Ventures](https://shizune.co/investors/profile/sis-ventures) — VC Fund, 1 deal together
- [Thairm Bio](https://shizune.co/investors/profile/thairm-bio) — VC Fund, 1 deal together

## About Kineticos Ventures

VC Fund · Morrisville, United States

Kineticos Ventures Invests in biotechs looking to disrupt how drugs are developed, diseases are diagnosed and patients are treated. We focus on the areas of greatest medical need: Oncology, Neurosciences, and Rare Diseases. We believe that disruptive technologies such as Cell and Gene Therapy, Gene Editing, mRNA/RNAi will dramatically changehow medicine is practiced.

2 contacts available at Kineticos Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Frank Lis | President and CEO | https://shizune.co/investors/profile/frank-lis-a5be |
| Shailesh Maingi | Founder & Exec Chair | https://shizune.co/investors/profile/shailesh-maingi-053a |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Frank Lis invest in?

Frank Lis invests primarily in Biotechnology, Health Care and Life Science startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Frank Lis?

Public channels for Frank Lis include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Frank Lis last invest?

The most recent investment recorded for Frank Lis closed in May 2023. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co